Torrent Pharmaceuticals Q4 FY26 Results Analyst Call Recording

• The document is a regulatory intimation regarding the availability of an audio recording for a Conference call with Analysts/Investors.
• The event was focused on the discussion of the company's Audited Financial Results for the quarter and year ended 31st March, 2026.
• The audio recording has been placed on the Company's website at the specific URL: https://www.torrentpharma.com/pdf/investors/Audio_Recording31032026.mp3.
• The letter is a continuation of previous communications dated 12-May-26 and 16-May-26.

Additional Notes Section

• The document is a compliance letter addressed to the listing departments of BSE Limited and the National Stock Exchange of India Ltd.
• No financial data, management participant names, or strategic updates were disclosed in this specific announcement.
• The document was digitally signed by CHINTAN M. TRIVEDI, COMPANY SECRETARY, on 22nd May, 2026 at 19:46:24 IST.